Merck Serono S.A. · Geneva Switzerland
| 9, Chemin Des Mines | Phone: +41-22-414-3000 |
| Geneva | Fax: +41-22-414-2179 |
| 1211 | |
| Switzerland | 
Map This Company |
Merck Serono S.A. Rankings
Company Description
The fertile minds at Merck Serono help people around the world combat infertility. One of the world's top biotechs, Merck Serono focuses on recombinant genetic engineering to develop drugs. The firm manufactures and markets therapies for neurological, metabolic, endocrinology, oncology, cardiovascular, and growth disorders, among others. It is a leader in reproductive health; flagship drug Gonal-F is a leading infertility product line. Other key products include beta interferon drug Rebif for the treatment of multiple sclerosis (MS) and colorectal and head/neck cancer treatment Erbitux. The company is German drugmaker
Merck Serono S.A. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiaryHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 640 |
Executives
19 executives listed for Merck Serono S.A.'s Geneva, Switzerland location.
| President | Stefan Oschmann | |
|---|---|---|
| COO | Belén Garijo | |
| EVP Global Business Unit CardioMetabolic Care and General Medicine; EVP Business Unit Emerging Markets | Franck Latrille |